Table of Contents Author Guidelines Submit a Manuscript
Journal of Lipids
Volume 2011, Article ID 670479, 8 pages
http://dx.doi.org/10.1155/2011/670479
Research Article

Regulation of Serum Response Factor and Adiponectin by PPAR Agonist Docosahexaenoic Acid

1Donald W. Reynolds Institute on Aging University of Arkansas for Medical Sciences, 4301 West Markham Street, Slot no. 748, Little Rock, AR 72205, USA
2Biology Department, University of Arkansas at Pine Bluff, Pine Bluff, AR 71601, USA
3Central Arkansas Veterans Healthcare System, 4300 West 7th Street, Little Rock, AR 72205, USA

Received 25 March 2010; Revised 18 June 2010; Accepted 3 August 2010

Academic Editor: Michel Lagarde

Copyright © 2011 Clayton Johnson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. M. Haffner, “Abdominal adiposity and cardiometabolic risk: do we have all the answers?” American Journal of Medicine, vol. 120, no. 9, pp. S10–S16, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Posern and R. Treisman, “Actin' together: serum response factor, its cofactors and the link to signal transduction,” Trends in Cell Biology, vol. 16, no. 11, pp. 588–596, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. G. C. T. Pipes, E. E. Creemers, and E. N. Olson, “The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis,” Genes and Development, vol. 20, no. 12, pp. 1545–1556, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Zhang, G. Azhar, J. Chai et al., “Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 280, no. 4, pp. H1782–H1792, 2001. View at Google Scholar · View at Scopus
  5. A. Parlakian, C. Charvet, B. Escoubet et al., “Temporally controlled onset of dilated cardiomyopathy through disruption of the srf gene in adult heart,” Circulation, vol. 112, no. 19, pp. 2930–2939, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Zhang, G. Azhar, M. C. Furr, Y. Zhong, and J. Y. Wei, “Model of functional cardiac aging: young adult mice with mild overexpression of serum response factor,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 285, no. 3, pp. R552–R560, 2003. View at Google Scholar · View at Scopus
  7. G. Azhar, X. Zhang, S. Wang, Y. Zhong, C. M. Quick, and J. Y. Wei, “Maintaining serum response factor activity in the older heart equal to that of the young adult is associated with better cardiac response to isoproterenol stress,” Basic Research in Cardiology, vol. 102, no. 3, pp. 233–244, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. Miano, “Role of serum response factor in the pathogenesis of disease,” Laboratory Investigation, vol. 90, no. 9, pp. 1274–1284, 2010. View at Publisher · View at Google Scholar
  9. N. Halberg, I. Wernstedt-Asterholm, and P. E. Scherer, “The adipocyte as an endocrine cell,” Endocrinology and Metabolism Clinics of North America, vol. 37, no. 3, pp. 753–768, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J.-Y. Kim, E. van de Wall, M. Laplante et al., “Obesity-associated improvements in metabolic profile through expansion of adipose tissue,” Journal of Clinical Investigation, vol. 117, no. 9, pp. 2621–2637, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. R. J. Deckelbaum, T. S. Worgall, and T. Seo, “n-3 fatty acids and gene expression,” American Journal of Clinical Nutrition, vol. 83, no. 6, p. 1520S, 2006. View at Google Scholar · View at Scopus
  12. S. Neschen, K. Morino, J. C. Rossbacher et al., “Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-γ-dependent mechanism in mice,” Diabetes, vol. 55, no. 4, pp. 924–928, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Banga, R. Unal, P. Tripathi et al., “Adiponectin translation is increased by the PPARγ agonists pioglitazone and ω-3 fatty acids,” American Journal of Physiology—Endocrinology and Metabolism, vol. 296, no. 3, pp. E480–E489, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Rodbell, “Metabolism of isolated fat cells. I. Effects of hormone on glucose metabolism and lipolysis,” Journal of Biological Chemistry, vol. 239, pp. 375–380, 1964. View at Google Scholar
  15. B. Saffari, J. M. Ong, and P. A. Kern, “Regulation of adipose tissue lipoprotein lipase gene expression by thyroid hormone in rats,” Journal of Lipid Research, vol. 33, no. 2, pp. 241–249, 1992. View at Google Scholar · View at Scopus
  16. H. Green and M. Meuth, “An established pre adipose cell line and its differentiation in culture,” Cell, vol. 3, no. 2, pp. 127–133, 1974. View at Google Scholar · View at Scopus
  17. J. Chang, L. Wei, T. Otani, K. A. Youker, M. L. Entman, and R. J. Schwartz, “Inhibitory cardiac transcription factor, SRF-N, is generated by caspase 3 cleavage in human heart failure and attenuated by ventricular unloading,” Circulation, vol. 108, no. 4, pp. 407–413, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. U. B. Pajvani, X. Du, T. P. Combs et al., “Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin: implications for metabolic regulation and bioactivity,” Journal of Biological Chemistry, vol. 278, no. 11, pp. 9073–9085, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Unal, A. Yao-Borengasser, V. Varma et al., “Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 6, pp. 2993–3001, 2010. View at Google Scholar
  20. M. Itoh, T. Suganami, N. Satoh et al., “Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 9, pp. 1918–1925, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Rasouli, A. Yao-Borengasser, L. M. Miles, S. C. Elbein, and P. A. Kern, “Increased plasma adiponectin in response to pioglitazone does not result from increased gene expression,” American Journal of Physiology—Endocrinology and Metabolism, vol. 290, no. 1, pp. E42–E46, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. A. M. Bodles, A. Banga, N. Rasouli, F. Ono, P. A. Kern, and R. J. Owens, “Pioglitazone increases secretion of high-molecular-weight adiponectin from adipocytes,” American Journal of Physiology—Endocrinology and Metabolism, vol. 291, no. 5, pp. E1100–E1105, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Abbasi, J. W. Chu, C. Lamendola et al., “Discrimination between obesity and insulin resistance in the relationship with adiponectin,” Diabetes, vol. 53, no. 3, pp. 585–590, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Tao, E. Gao, X. Jiao et al., “Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress,” Circulation, vol. 115, no. 11, pp. 1408–1416, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Gauthier-Rouviere, M. Vandromme, D. Tuil et al., “Expression and activity of serum response factor is required for expression of the muscle-determining factor MyoD in both dividing and differentiating mouse C2C12 myoblasts,” Molecular Biology of the Cell, vol. 7, no. 5, pp. 719–729, 1996. View at Google Scholar · View at Scopus
  26. K. Sakuma, M. Akiho, H. Nakashima, H. Akima, and M. Yasuhara, “Age-related reductions in expression of serum response factor and myocardin-related transcription factor A in mouse skeletal muscles,” Biochimica et Biophysica Acta, vol. 1782, no. 7-8, pp. 453–461, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Bełtowski, A. Jamroz-Wiśniewska, and S. Widomska, “Adiponectin and its role in cardiovascular diseases,” Cardiovascular and Hematological Disorders—Drug Targets, vol. 8, no. 1, pp. 7–46, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Inoue, N. Kotooka, T. Morooka et al., “High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease,” American Journal of Cardiology, vol. 100, no. 4, pp. 569–574, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. B. B. Duncan, M. I. Schmidt, J. S. Pankow et al., “Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study,” Diabetes, vol. 53, no. 9, pp. 2473–2478, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. R. C. Valentine and D. L. Valentine, “Omega-3 fatty acids in cellular membranes: a unified concept,” Progress in Lipid Research, vol. 43, no. 5, pp. 383–402, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Shibata, K. Sato, D. R. Pimentel et al., “Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms,” Nature Medicine, vol. 11, no. 10, pp. 1096–1103, 2005. View at Publisher · View at Google Scholar · View at Scopus